Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFS.L Regulatory News (AFS)

  • There is currently no data for AFS

Director/PDMR Shareholding

29 Oct 2012 10:17

RNS Number : 7371P
Amiad Water Systems Ltd
29 October 2012
 



29 October 2012

 

Amiad Water Systems Ltd.

("Amiad" or the "Company")

 

Director Dealings

 

Amiad Water Systems (AIM: AFS), a leading global producer of water treatment and filtration solutions, announces that it received notification today that Simon Olswang, a non-executive director of the Company, has on 25 October sold 10,000 ordinary shares of 0.5 NIS each ("Ordinary Shares") at a price of 305 pence per share and on 26 October sold 20,000 Ordinary Shares at a price of 304 pence per share.

 

Following this sale, Simon Olswang has an interest in 19,500 Ordinary Shares representing 0.1% of the entire issued share capital of the Company.

 

 

Enquiries:

 

Amiad Water Systems Ltd.

Arik Dayan, Chief Executive Officer

Amir Harel, Chief Financial Officer

+972 4 690 9500

Nomura Code Securities Ltd.

Chris Collins, Giles Balleny

+44 20 7776 1200

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBKLFLLBFFFBE
Date   Source Headline
26th Aug 20217:00 amRNSCancellation - Amiad Water Systems Ltd
23rd Aug 20212:05 pmRNSSecond Price Monitoring Extn
23rd Aug 20212:00 pmRNSPrice Monitoring Extension
23rd Aug 20219:47 amRNSFirst Day of Dealings on TASE
19th Aug 20216:00 pmRNSAmiad Water Systems
12th Aug 20211:38 pmRNSTransfer of Listing
10th Aug 20214:14 pmRNSUpdate on Transfer of Listing
29th Jul 202112:38 pmRNSResult of AGM and EGM
23rd Jul 20217:00 amRNSUpdate on Transfer of Listing to TASE
19th Jul 20214:20 pmRNSUpdate on AGM and EGM
9th Jul 20217:00 amRNSRelated Party Transaction
30th Jun 20213:59 pmRNSDirectorate Change
23rd Jun 20213:14 pmRNSPublication of Circular and Notice of Meetings
11th Jun 20217:00 amRNSChange in Significant Shareholding
3rd Jun 20214:19 pmRNSPublication of Annual Report
11th May 20213:29 pmRNSIssue of Equity and TVR
6th May 202111:54 amRNSResult of EGM and Directorate Change
5th May 20217:00 amRNSPDMR Shareholding
28th Apr 20213:40 pmRNSProposed transfer of listing to TASE
8th Apr 20211:38 pmRNSPDMR Shareholding, Issue of Equity and TVR
26th Mar 20217:00 amRNSFull Year Results
26th Mar 20217:00 amRNSNotice of EGM and Director Appointments
19th Mar 202111:05 amRNSSecond Price Monitoring Extn
19th Mar 202111:00 amRNSPrice Monitoring Extension
3rd Mar 20217:00 amRNSDirectorate Change
2nd Mar 20217:00 amRNSAmiad launches the Spin Klin Nova
19th Feb 20213:53 pmRNSIssue of Equity and TVR
27th Jan 20217:00 amRNSIssue of Equity and TVR
24th Dec 20209:55 amRNSResult of AGM
16th Dec 20204:44 pmRNSAdjournment of AGM
8th Dec 20207:00 amRNSAppointment of CFO
5th Nov 20202:09 pmRNSNotice of AGM
28th Oct 20207:00 amRNSManagement Change
27th Oct 20207:00 amRNSOptions exercise, issue of equity and TVR
10th Sep 20207:00 amRNSInterim Results
20th Jul 202012:06 pmRNSRelated Party Transactions
13th Jul 20203:44 pmRNSPDMR Shareholding
30th Jun 20209:34 amRNSPDMR Shareholding, Issue of Equity and TVR
16th Jun 20207:00 amRNSNew five-year agreement with Netafim
11th Jun 20207:00 amRNSPublication of Annual Report and Accounts
10th Jun 20207:00 amRNSExercise of Options, Issue of Equity and TVR
1st May 20202:55 pmRNSHolding(s) in Company
1st May 20202:07 pmRNSHolding(s) in Company
1st May 20208:00 amRNSCompletion of Investment and Directorate Change
29th Apr 20208:51 amRNSResults of Open Offer and Subscription and TVR
24th Apr 20207:00 amRNSCOVID-19 Update
8th Apr 20202:26 pmRNSLaunch of Open Offer
7th Apr 20209:15 amRNSUpdate on Potential Investment
2nd Apr 20201:42 pmRNSResult of EGM and Directorate Change
26th Mar 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.